| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbd36ccbcf8eb717249faf9a08d3abbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81afd7465ffba8139e557bd8c35b5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-11 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate |
2021-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21df4dcfdb6fb80ddc825e3faecd245e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5364fcf6f835faa659d1d0fae035640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c31d69bd32d4ffed86fba57ce272d96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f07dc7a895810c1b587c846285dda36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80c2fed885320f723fcf9666b8dfd613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_417b354527a0f9180a5d486d9ea5a64c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a36ca8a330e1b25aadfec8360ff4d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cabf85afd4a84ea42c6e4af0725e5f93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd12817dea2c923b792bf0d5df0c1e4 |
| publicationDate |
2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220018953-A |
| titleOfInvention |
Antivirus composition comprising Pteridium aquilinum extract or fraction thereof |
| abstract |
The present invention relates to an antiviral composition comprising a bracken extract or a fraction thereof, and more particularly, to a composition for preventing or treating RNA virus infection comprising a bracken rhizome extract or a fraction thereof as an active ingredient. The bracken extract provided by the present invention has excellent activity of inhibiting reverse transcriptase and inhibiting the proliferation of RNA viruses, and thus can be very usefully utilized for the prevention or development of therapeutic agents for RNA virus infections. |
| priorityDate |
2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |